GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Poniard Pharmaceuticals PARD · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Poniard Pharmaceuticals — daily PARD Delayed
Market value
$117
Last close × shares
Volume
7
Shares, 30 Oct 2026

About Poniard Pharmaceuticals

Its shares trade under the ticker PARD. It has been listed since 30 December 2011.

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of oncology products. The company is headquartered in San Francisco, California. The company went IPO on 2011-12-30. The firm focuses on the development and commercialization of oncology products to impact the lives of people with cancer. The company develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The firm has offices in San Francisco, California; and Seattle, Washington in United States.

Figures and description from our data supplier, not checked against the company's own report.

More about Poniard Pharmaceuticals →

Latest on Poniard Pharmaceuticals

Our reporting

We have not reported on Poniard Pharmaceuticals yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Poniard Pharmaceuticals's ticker?

Poniard Pharmaceuticals trades as PARD on its US listing, under ISIN US7324494001.

What was Poniard Pharmaceuticals's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.